🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

89 results for “INTEGRATED BIOPHARMA INC” Clear

  1. BaidI Quzhi granule

    INTEGRATED BIOPHARMA INC

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  2. Donepezil

    INTEGRATED BIOPHARMA INC

    Osteoarthritis

    phase 3 small molecule active

    1 trial

  3. Ear pills

    INTEGRATED BIOPHARMA INC

    Intradialytic Hypotension

    phase 3 small molecule active

    1 trial

  4. G-Pen

    INTEGRATED BIOPHARMA INC

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial

  5. Galantamine

    INTEGRATED BIOPHARMA INC

    Acute Ischemic Stroke AIS

    phase 3 small molecule active

    1 trial

  6. Ginkgo Diterpene Lactone Meglumine Injection

    INTEGRATED BIOPHARMA INC

    Ischemic Stroke

    phase 3 small molecule active

    1 trial

  7. Ginkgo diterpene lactone meglumine injection

    INTEGRATED BIOPHARMA INC

    Ischemic Stroke, Acute

    phase 3 small molecule active

    1 trial

  8. Infliximab + methotrexate (IFX + MTX)

    INTEGRATED BIOPHARMA INC

    Arthritis, Psoriatic

    phase 3 small molecule completed

    1 trial

  9. Infliximab Increased Frequency

    INTEGRATED BIOPHARMA INC

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial

  10. Intensive medical therapy

    INTEGRATED BIOPHARMA INC

    Myocardial Ischemia

    phase 3 other completed

    1 trial

  11. Juanbi pill

    INTEGRATED BIOPHARMA INC

    Juanbi Pill

    phase 3 small molecule active

    1 trial

  12. NiuBangZi pill or NiuBangZi pill placebo

    INTEGRATED BIOPHARMA INC

    Niu Bang Zi Pill

    phase 3 small molecule active

    1 trial

  13. PEG-Interferon a-2b + Ribavirin

    INTEGRATED BIOPHARMA INC

    Chronic Hepatitis C Infection in HIV-Infected Persons

    phase 3 small molecule completed

    1 trial

  14. Peg interferon alpha-2b

    INTEGRATED BIOPHARMA INC

    Hepatitis C

    phase 3 small molecule terminated

    1 trial

  15. PegIntron (peginterferon alfa-2b)

    INTEGRATED BIOPHARMA INC

    Hepatitis C, Chronic

    phase 3 mab terminated

    1 trial

  16. Picosulfate sodium, magnesium oxide, citric acid

    INTEGRATED BIOPHARMA INC

    Bowel Preparation Before Colonoscopy

    phase 3 small molecule completed

    1 trial

  17. Qing'E pills

    INTEGRATED BIOPHARMA INC

    Menopause

    phase 3 small molecule completed

    1 trial

  18. Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)

    INTEGRATED BIOPHARMA INC

    Bowel Preparation

    phase 3 small molecule completed

    1 trial

  19. Sevoflurane

    INTEGRATED BIOPHARMA INC

    Anesthesia

    phase 3 small molecule completed

    1 trial

  20. Surgery and HIPEC with Lobaplatin

    INTEGRATED BIOPHARMA INC

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  21. Tirofiban

    INTEGRATED BIOPHARMA INC

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  22. peginterferon alfa-2b (SCH 54031)

    INTEGRATED BIOPHARMA INC

    Hepatitis C, Chronic

    phase 3 mab completed

    1 trial

  23. 0.9% NaCl 2000ml

    INTEGRATED BIOPHARMA INC

    Brain Infarct

    phase 2 small molecule completed

    1 trial

  24. Autologous CD5 CAR T-cells

    INTEGRATED BIOPHARMA INC

    T-Cell Acute Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources